首页 | 本学科首页   官方微博 | 高级检索  
检索        

长春瑞滨联合顺铂治疗晚期非小细胞肺癌临床观察
引用本文:王志强,张健国,刘刚.长春瑞滨联合顺铂治疗晚期非小细胞肺癌临床观察[J].医学研究杂志,2005,34(2):42-43.
作者姓名:王志强  张健国  刘刚
作者单位:1. 黑龙江省牡丹江医学院红旗医院肿瘤科,157011
2. 牡丹江市肿瘤医院
摘    要:目的比较长春瑞滨(NVB)加顺铂(DDP)与环磷酰胺(CTX)加阿霉素(ADM)加顺铂(DDP)两方案治疗晚期非小细胞肺癌的疗效。方法随机将62例患者分为 NP 组(32例)和 CAP 组(30例),均化疗2疗程,疗效评价按 WHO疗效标准,总有效率以 CR PR 计算。结果总有效率 NP 组46.8%,GAP 组20.0%,χ~2=4.99,P<0.05,两者有显著差异。结论 NP 方案治疗晚期非小细胞肺癌疗效较好,高于 CAP 方案。

关 键 词:长春瑞滨  联合化疗  晚期非小细胞肺癌  疗效
修稿时间:2004年12月3日

The Effects of Combined Chemotherapy Vinorelbine plus Cisplatin in the treatment of 32 cases with advanced non-small cell lung cancer
Wang Zhiqiang Zhang Jianguo Liu Gang.The Effects of Combined Chemotherapy Vinorelbine plus Cisplatin in the treatment of 32 cases with advanced non-small cell lung cancer[J].Journal of Medical Research,2005,34(2):42-43.
Authors:Wang Zhiqiang Zhang Jianguo Liu Gang
Institution:Wang Zhiqiang Zhang Jianguo Liu Gang Department of Oncology,Mudanjiang Medical College HongQi Hospital
Abstract:Objective To compare the Curative effect of NP regimen(NVB DDP)with that of CAP regimen(CTX ADM DDP)for advanced non-small cell lung cancer(NSCLE).Methods 62 patients with NSCLC were randomly divided into NP group(32 cases)and CAP group(30 cases).Both were treated with chemotherapy for two courses of treatment.According to WHO's standed,the Curative were evaluat- ed.Overall response rates were caculated with CR PR.Results The Overall response rates of NP group and CAP group were 46.8% and 20.0%,respectively(x~2=4.99,P<0.05).Conclution The curative effect of the regiment of NVB DDP for combined chemotherapy for advanced non-small cell lung cancer is better than that of the CAP regimen.It's an effective regimen for treatment of non-small cell lung cancer.
Keywords:Vinorelbine  Combined chemotherapy  Advanced non-small cell lung cancer  Curative effect
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《医学研究杂志》浏览原始摘要信息
点击此处可从《医学研究杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号